Fecal Microbiota Transplantation: Is It Safe?

Area of Science:

• Microbiology
• Gastroenterology
• Infectious Diseases

Background:

• Fecal microbiota transplantation (FMT) is an established treatment for recurrent Clostridioides difficile infections.
• FMT is generally well-tolerated, with most short-term risks linked to administration methods.
• Long-term safety data for FMT is still limited, with no established harm to date.

Purpose of the Study:

• To review and discuss the adverse events and safety concerns associated with FMT.
• To highlight potential risks, including those from contaminated FMT products and the need for comprehensive screening.

Main Methods:

• Review of existing literature on FMT adverse events.
• Analysis of safety data and reported side effects.
• Discussion of screening protocols and their impact on FMT safety.

Main Results:

• Short-term adverse events are typically mild and related to delivery methods.
• Long-term side effects of FMT are not yet fully established.
• Serious adverse events have been linked to FMT products lacking multi-drug resistant organism screening.

Conclusions:

• FMT is generally safe for recurrent C. difficile infections, but vigilance is required.
• Enhanced donor screening, particularly for multi-drug resistant organisms, is crucial for FMT safety.
• Further research is needed to fully understand long-term safety and causality of microbiome-associated diseases.